Figure 1A-B illustrated a pronounced upregulation of SLC7A11 in tumor samples within the TCGA-GTEx-GBMLGG dataset (P < 0.001), with a consequential divergence in survival probability between cohorts characterized by high versus low SLC7A11 expression (P = 0.010). Here, SLC7A11 is linked to neoplasm.